Brand family
Rybrevant Faspro
Amivantamab and Hyaluronidase (human recombinant) · Janssen Biotech
United States
- Presentations
- 4
- Markets
- 1
Rybrevant Faspro is a brand of Amivantamab and Hyaluronidase (human recombinant) marketed by Janssen Biotech, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Amivantamab and Hyaluronidase (human recombinant)
- Brand owner
- Janssen Biotech
- Registered in
- United States
- Strengths and forms
- 1600 mg/20000 mg per 10 mL injection, 2240 mg/28000 mg per 14 mL injection, 2400 mg/30000 mg per 15 mL injection, 3520 mg/44000 mg per 22 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Rybrevant Faspro 1600 mg/20000 mg per 10 mL injectionSubcutaneous Cold chain | Janssen Biotech | US FDA | Available on request |
| Rybrevant Faspro 2240 mg/28000 mg per 14 mL injectionSubcutaneous Cold chain | Janssen Biotech | US FDA | Available on request |
| Rybrevant Faspro 2400 mg/30000 mg per 15 mL injectionSubcutaneous Cold chain | Janssen Biotech | US FDA | Available on request |
| Rybrevant Faspro 3520 mg/44000 mg per 22 mL injectionSubcutaneous Cold chain | Janssen Biotech | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Rybrevant Faspro
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.